213 filings
Page 3 of 11
UPLOAD
mshkndoue48pshl9ugdp
8 Mar 23
Letter from SEC
12:00am
8-K
hxyd5le6ejn 0t
3 Mar 23
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
8:05am
8-K
sdix1sq7zew2e59qe8p
19 Jan 23
Entry into a Material Definitive Agreement
4:14pm
424B5
14d6gi5htk0z6ct
19 Jan 23
Prospectus supplement for primary offering
4:05pm
8-K
5mbwiqeo1 t6
10 Jan 23
Other Events
7:05am
S-8
ig01qq
4 Jan 23
Registration of securities for employees
4:13pm
8-K
dmorl9
27 Dec 22
Entry into a Material Definitive Agreement
4:13pm
8-K
5u7u0wr15fu9n
9 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
74vvhspkfa64xs8 46
28 Nov 22
Entry into a Material Definitive Agreement
4:52pm
8-K
o8821b7 j1ph9
8 Nov 22
Kala Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
8:05am
8-K
s2u7zdo
1 Nov 22
Departure of Directors or Certain Officers
4:05pm
8-K
rws5dx55lj9hb
20 Oct 22
Kala Pharmaceuticals Announces Reverse Stock Split
4:01pm
PRE 14A
3o04hez skeht
30 Aug 22
Preliminary proxy
5:00pm
8-K
86tcy
19 Aug 22
Kala Pharmaceuticals Announces Distribution of Series D Preferred Stock to Holders of its Common Stock
7:08am